Investor Relations

Investor Presentation

View our latest Investor Presentation to find the most recent investor-related information.

View Investor Presentation

Stock Information

View Detailed Stock Information

Latest News

View All News
Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board
Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology
Envoy Medical Reports on Second Quarter 2025 Results

Latest Financial Results

Q2 2025

Quarter Ended Jun 30, 2025

Company Overview

Envoy Medical (NASDAQ: COCH) is a hearing health company focused on providing innovative technologies across the hearing loss spectrum. Envoy Medical has pioneered one-of-a-kind, fully implanted devices for hearing loss, including its fully implanted Esteem® active middle ear implant, commercially available in the U.S. since 2010, and the fully implanted Acclaim® cochlear implant, an investigational device. Envoy Medical is dedicated to pushing hearing technology beyond the status quo to improve access, usability, compliance, and ultimately quality of life.

View Leadership Team View Board of Directors View Media

CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.

IR Contacts

Corporate Office

Envoy Medical, Inc.
4785 White Bear Parkway
White Bear Lake, MN 55110

Investor Relations

Phone: 651-361-8043
InvestorRelations@EnvoyMedical.com

KCSA Strategic Communications
Phil Carlson
Phone: 212-896-1233
pcarlson@kcsa.com

Transfer Agent

Equiniti Trust Company LLC
Phone: 718-921-8124
help@equiniti.com
https://equiniti.com/us/ast-access/individuals